|
1
|
Morel O, Kessler L, Ohlmann P and Bareiss
P: Diabetes and the platelet: Toward new therapeutic paradigms for
diabetic atherothrombosis. Atherosclerosis. 212:367–376. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gaede P, Lund-Andersen H, Parving HH and
Pedersen O: Effect of a multifactorial intervention on mortality in
type 2 diabetes. N Engl J Med. 358:580–591. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Santi D, Giannetta E, Isidori AM, Vitale
C, Aversa A and Simoni M: Therapy of endocrine disease. Effects of
chronic use of phosphodiesterase inhibitors on endothelial markers
in type 2 diabetes mellitus: A meta-analysis. Eur J Endocrinol.
172:R103–R114. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chazova TE, Masenko VP, Zykov KA and
Golitsyna TIu: The role of inflammation factors in development of
acute coronary syndrome in patients with type 2 diabetes mellitus
and impaired glucose tolerance. Ter Arkh. 79:60–64. 2007.(In
Russian). PubMed/NCBI
|
|
5
|
Mahmoud F and Al-Ozairi E: Inflammatory
cytokines and the risk of cardiovascular complications in type 2
diabetes. Dis Markers. 35:235–241. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rothenbacher D, Brenner H, März W and
Koenig W: Adiponectin, risk of coronary heart disease and
correlations with cardiovascular risk markers. Eur Heart J.
26:1640–1646. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kim JA, Montagnani M, Koh KK and Quon MJ:
Reciprocal relationships between insulin resistance and endothelial
dysfunction: Molecular and pathophysiological mechanisms.
Circulation. 113:1888–1904. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lee MJ, Yang RZ, Gong DW and Fried SK:
Feeding and insulin increase leptin translation. Importance of the
leptin mRNA untranslated regions. J Biol Chem. 282:72–80. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
el-Mesallamy H, Suwailem S and Hamdy N:
Evaluation of C-reactive protein, endothelin-1, adhesion
molecule(s), and lipids as inflammatory markers in type 2 diabetes
mellitus patients. Mediators Inflamm. 2007:736352007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pfützner A and Forst T: High-sensitivity
C-reactive protein as cardiovascular risk marker in patients with
diabetes mellitus. Diabetes Technol Ther. 8:28–36. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Barzilay JI, Abraham L, Heckbert SR,
Cushman M, Kuller LH, Resnick HE and Tracy RP: The relation of
markers of inflammation to the development of glucose disorders in
the elderly: The Cardiovascular Health Study. Diabetes.
50:2384–2389. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Torimoto K, Okada Y, Mori H, Otsuka T,
Kawaguchi M, Matsuda M, Kuno F, Sugai K, Sonoda S, Hajime M, et al:
Effects of exenatide on postprandial vascular endothelial
dysfunction in type 2 diabetes mellitus. Cardiovasc Diabetol.
14:252015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zaghloul A, Al-Bukhari TA, Al-Pakistani
HA, Shalaby M, Halawani SH, Bajuaifer N and Teama SH: Soluble
endothelial protein C receptor and high sensitivity C reactive
protein levels as markers of endothelial dysfunction in patients
with type 1 and type 2 diabetes mellitus: Their role in the
prediction of vascular complications. Diabetes Res Clin Pract.
106:597–604. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Knudson JD, Dincer UD, Zhang C, Swafford
AN Jr, Koshida R, Picchi A, Focardi M, Dick GM and Tune JD: Leptin
receptors are expressed in coronary arteries, and hyperleptinemia
causes significant coronary endothelial dysfunction. Am J Physiol
Heart Circ Physiol. 289:H48–H56. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen K, Li F, Li J, Cai H, Strom S,
Bisello A, Kelley DE, Friedman-Einat M, Skibinski GA, McCrory MA,
et al: Induction of leptin resistance through direct interaction of
C-reactive protein with leptin. Nat Med. 12:425–432. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Johnson JL, Fritsche-Danielson R, Behrendt
M, Westin-Eriksson A, Wennbo H, Herslof M, Elebring M, George SJ,
McPheat WL and Jackson CL: Effect of broad-spectrum matrix
metalloproteinase inhibition on atherosclerotic plaque stability.
Cardiovasc Res. 71:586–595. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Vozarova B, Weyer C, Hanson K, Tataranni
PA, Bogardus C and Pratley RE: Circulating interleukin-6 in
relation to adiposity, insulin action, and insulin secretion. Obes
Res. 9:414–417. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
De Rosa S, Cirillo P, Pacileo M, Di Palma
V, Paglia A and Chiariello M: Leptin stimulated C-reactive protein
production by human coronary artery endothelial cells. J Vasc Res.
46:609–617. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ragab A, Abousamra NK, Higazy A and Saleh
O: Relationship between insulin resistance and some coagulation and
fibrinolytic parameters in patients with metabolic syndrome. Lab
Hematol. 14:1–6. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Singh P, Hoffmann M, Wolk R, Shamsuzzaman
AS and Somers VK: Leptin induces C-reactive protein expression in
vascular endothelial cells. Arterioscler Thromb Vasc Biol.
27:e302–e307. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kosztáczky B, Fóris G, Paragh G Jr, Seres
I, Zsiros E, Koncsos P, Balogh Z and Paragh G: Leptin stimulates
endogenous cholesterol synthesis in human monocytes: New role of an
old player in atherosclerotic plaque formation. Leptin-induced
increase in cholesterol synthesis. Int J Biochem Cell Biol.
39:1637–1645. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Maya-Monteiro CM, Almeida PE, D'Avila H,
Martins AS, Rezende AP, Castro-Faria-Neto H and Bozza PT: Leptin
induces macrophage lipid body formation by a phosphatidylinositol
3-kinase- and mammalian target of rapamycin-dependent mechanism. J
Biol Chem. 283:2203–2210. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Korda M, Kubant R, Patton S and Malinski
T: Leptin-induced endothelial dysfunction in obesity. Am J Physiol
Heart Circ Physiol. 295:H1514–H1521. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Taleb S, Herbin O, Ait-Oufella H, Verreth
W, Gourdy P, Barateau V, Merval R, Esposito B, Clément K, Holvoet
P, et al: Defective leptin/leptin receptor signaling improves
regulatory T cell immune response and protects mice from
atherosclerosis. Arterioscler Thromb Vasc Biol. 27:2691–2698. 2007.
View Article : Google Scholar : PubMed/NCBI
|
